Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 5/20 | 0.59 |
| ▸ | FAAH | O00519 | 3/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 10/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7749309 | 1.00 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL7197883 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL717660 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL5971231 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL7201455 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL718241 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL719828 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL7194191 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL7749238 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 | |
| SCHEMBL717652 | 0.96 | MGLL (0.59) | MGLLFAAHPTGS1PTGS2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5043441-A | Enhance penetration of active materials through skin | WHITBY RESEARCH, INC. (US) | 1991-08-27 | — | — | US | claimed |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| US-6184180-B1 | COMPRISES SUPPORT, REVERSIBLE HEAT-SENSITIVE RECORDING LAYER CONTAINING DYE PRECURSOR WHICH IS COLORLESS OR A PALE COLOR, COLOR DEVELOPER CAPABLE OF CAUSING REVERSIBLE CHANGE IN COLOR DENSITY OF DYE DUE TO DIFFERENCE IN COOLING RATE | MITSUBISHI PAPER MILLS LIMITED (JP) | 2001-02-06 | — | — | US | disclosed |
| US-5817599-A | COLORLESS DYE PRECURSOR AND REVERSIBLE COLOR DEVELOPER | MITSUBISHI PAPER MILLS LIMITED (JP) | 1998-10-06 | — | — | US | disclosed |
| EP-0257086-B1 | SKINPENETRATION ENHANCING COMPOSITIONS | WHITBY RESEARCH, Inc. (US) | 1993-01-20 | — | — | EP | disclosed |
| EP-0268218-B1 | PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS | WHITBY RESEARCH, Inc. (US) | 1992-05-06 | — | — | EP | disclosed |
| US-5043441-A | Enhance penetration of active materials through skin | WHITBY RESEARCH, INC. (US) | 1991-08-27 | — | — | US | disclosed |
| US-5034386-A | Fungicides | WHITBY RESEARCH, INC. (US) | 1991-07-23 | — | — | US | disclosed |
| US-4886783-A | Penetration enhancers for transdermal delivery of systemic agents | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1989-12-12 | — | — | US | disclosed |
| US-4886545-A | IMPROVE DELIVERY OF PLANT NUTRIENTS | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1989-12-12 | — | — | US | disclosed |
| EP-0268218-A2 | Penetration enhancers for transdermal delivery of systemic agents | WHITBY RESEARCH, Inc. (US) | 1988-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | MGLL 118/4885FAAH 3/4885PTGS1 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.